Actionable news
0
All posts from Actionable news
Actionable news in TLGT: TELIGENT INC,

Teligent, Inc. Announces FDA Approval Of Triamcinolone Acetonide Ointment USP, 0.1%

BUENA, N.J., May 16, 2016 /PRNewswire/ -- Teligent, Inc. (TLGT), a New Jersey-based specialty generic pharmaceutical company, announced today that it has received approval of the Company's abbreviated new drug application (ANDA) from the U.S. Food and Drug Administration (FDA) of Triamcinolone Acetonide Ointment USP, 0.1%. This is Teligent's fifth approval from its internally developed pipeline of topical generic pharmaceutical products.

View photo

.
Teligent (PRNewsFoto/Teligent, Inc.)

Based on IMS Health data from March 2016, the total addressable market for Triamcinolone Acetonide Ointment USP, 0.1% is approximately $24 million. Teligent originally submitted this ANDA to the FDA in January 2013.

"This is our fourth prescription topical ANDA approved by the FDA so far this year, including the recent approval of a partnered submission," commented Jason Grenfell-Gardner, President and CEO of the Company. "Our commercialization team expects to launch Triamcinolone Acetonide Ointment USP, 0.1% in the second quarter of 2016. This will be the...


More